You must be signed in to view this page
Ibrutinib in Relapsed or Refractory Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Volume 5, Number 5 (Sep/Oct 2014)
DOI: 10.6004/jadpro.2014.5.5.5